25 July 2018

Posting of Annual Report and Notice of AGM

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, confirms that the Annual Report and Accounts for the year ended 31 March 2018 ('2018 Annual Report and Accounts'), the Notice of Annual General Meeting ('AGM') and a Form of Proxy will be posted to shareholders on 26 July 2018. A copy of the 2018 Annual Report and Accounts will be available to download from the Company website from that date.

The AGM will be held at 11.00am on 22 August 2018 at 3 Robroyston Oval, Nova Business Park, Glasgow G33 1AP.

For additional information on Collagen Solutions, please visit: www.collagensolutions.com


Collagen Solutions Plc
Jamal Rushdy, CEO
Hilary Spence, CFO
Via Walbrook
Lisa Baderoon, Head of Investor Relations Tel: +44 (0) 7721 413 496 or lisa.baderoon@collagensolutions.com
Cenkos Securities plc (Nominated Adviser and Broker)
Steve Cox (Corporate Finance)
Stephen Keys
Tel: 0207 397 8900
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001
Helen Cresswell Mob: 07841 917 679


About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For more information go to: www.collagensolutions.com.